Medicinal Products

Dáil Éireann Debate, Thursday - 25 June 2026

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Thursday, 25 June 2026

Questions (414)

Paul McAuliffe

Question:

414. Deputy Paul McAuliffe asked the Minister for Health if she will consider approving the payment of off-label low dose naltrexone as part of the drugs payment scheme for the treatment of long-Covid patients; and if she will make a statement on the matter. [48375/26]

Written answers

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

• Previous Answer
• Next Answer